LobbyingGE Healthcare Technologies lobbying by quarter
GE Healthcare Technologies GEHC's latest lobbying report covers Q2 2026, at $350K. The four quarters Q4 2025–Q3 2026 total $1.4M. Its first report covers Q1 2023; the issues it reports most are Health Issues.
GE Healthcare TechnologiesGEHC
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.4M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $240K | 1 |
| Q2 2023 | $160K | 1 |
| Q3 2023 | $130K | 1 |
| Q4 2023 | $90K | 1 |
| Q1 2024 | $190K | 1 |
| Q2 2024 | $190K | 1 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $220K | 1 |
| Q1 2025 | $550K | 1 |
| Q2 2025 | $350K | 1 |
| Q3 2025 | $370K | 1 |
| Q4 2025 | $380K | 1 |
| Q1 2026 | $700K | 1 |
| Q2 2026 | $350K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$4M · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Commerce, Dept of (DOC)14 reports
- Health & Human Services, Dept of (HHS)14 reports
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
- U.S. Trade Representative (USTR)14 reports
- Treasury, Dept of13 reports
- Office of Management & Budget (OMB)4 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseGE Healthcare Technologies | $4M | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $350K |
| 04/20for Q1 | In-house | $700K |
| 01/20for Q4 2025 | In-house | $380K |
| 25/10/20for Q3 2025 | In-house | $370K |
| 25/07/21for Q2 2025 | In-house | $350K |
| 25/04/21for Q1 2025 | In-house | $550K |
| 25/01/21for Q4 2024 | In-house | $220K |
| 24/10/21for Q3 2024 | In-house | $80K |
| 24/07/22for Q2 2024 | In-house | $190K |
| 24/04/22for Q1 2024 | In-house | $190K |
| 24/01/22for Q4 2023 | In-house | $90K |
| 23/10/20for Q3 2023 | In-house | $130K |
| 23/07/20for Q2 2023 | In-house | $160K |
| 23/04/20for Q1 2023 | In-house | $240K |
| 23/03/31for Q1 2023 | In-house | Under $5,000 |